-The United Nations The Asia-Pacific region, which has overtaken the rest of the world in consumption of raw materials as affluence and manufacturing increase, must boost its resource efficiency or risk losing ground in lifestyle, economic growth and environmental sustainability, according to a UN report released today. From 1970-2008, consumption of construction minerals increased 13.4 times, metal ores and industrial minerals consumption 8.6, fossil fuels 5.4, and biomass 2.7 times, according to...

-The Hindu The Saradha group's spectacular failure has inflicted severe pain not only on its gullible depositors and agents but in a real sense on India's financial regulators and the State government as well. There is a law and order problem in West Bengal. Very soon, public attention will shift to regulation or the lack of it. The crisis, it appears, will not be confined to one state. In the worst...

-The Hindu The spectacular failure of the Saradha Group domiciled in West Bengal but also operating in a few adjoining States reinforces certain important messages from past scams. The first lesson to investors and regulators alike is that it is still possible for unscrupulous promoters to design and operate Ponzi schemes built around promises of extraordinary returns that are clearly unsustainable. Such schemes depend upon a steady stream of fresh deposits...

-Frontline Is there a shift in the attitude of Kerala society towards the value of daughters? Is son preference spreading in a State once known to be above extreme gender bias? A recent study on child sex ratio generates more questions than it answers. By R. KRISHNAKUMAR in Thiruvananthapuram ABORTION of female foetuses after parents learn of their gender using medical diagnostic techniques is believed to be one of the central reasons...

The recent Supreme Court judgment dismissing pharma giant Novartis’ claim for patent protections in India for its award-winning and prohibitively priced anti-leukemia drug Glivec has renewed the focus on accessibly-priced drugs – in particular the failure of the Indian public healthcare system and health policy to ensure affordable drugs for all. Studies show that as much as 70% of health spending in India comes from out-of-pocket payments, with 50-80% of...